OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis

INTRODUCTION: The power of ‘real world’ data to improve our understanding of the clinical aspects of multiple sclerosis (MS) is starting to be realised. Disease modifying therapy (DMT) use across the UK is driven by national prescribing guidelines. As such, the UK provides an ideal country in which...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobson, Ruth, Craner, Matthew, Waddingham, Ed, Miller, Aleisha, Cavey, Ana, Webb, Stewart, Hemingway, Cheryl, Hobart, Jeremy, Evangelou, Nikos, Scolding, Neil, Rog, David, Nicholas, Richard, Marta, Monica, Blain, Camilla, Young, Carolyn Anne, Ford, Helen L, Matthews, Paul M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627413/
https://www.ncbi.nlm.nih.gov/pubmed/34824113
http://dx.doi.org/10.1136/bmjopen-2021-050176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627413/
https://www.ncbi.nlm.nih.gov/pubmed/34824113
http://dx.doi.org/10.1136/bmjopen-2021-050176

Ejemplares similares